Leap Therapeutics (LPTX) Financials

$1.58

$-0.47 (-22.93%)

As on 11-Dec-2025 09:30EDT

Market cap

$116 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

27.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.44	--	--	0.38	1.50	10.05
Cost of Revenue	31.01	0.01	0.43	0.42	--	4.93
Gross Profit	-30.57	-0.01	-0.43	-0.42	1.50	5.12
Operating Expenses	75.07	70.06	86.61	56.76	42.93	8.57
Operating Profit (EBIT)	-105.64	-70.06	-87.04	-56.76	-41.43	-3.45
Other Income	--	--	--	--	-0.38	0.74
Profit before Tax	-100.25	-66.97	-81.41	-54.45	-40.61	-3.39
Provision for Tax	-2.30	0.59	--	0.15	-0.02	0.00
Profit after Tax (Net Income)	-98.22	-67.56	-81.41	-54.60	-40.59	-3.39
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-54.60	-40.59	-37.59

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	2.70	35.05	60.14	54.64	107.89	67.41
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	0.33	0.04	1.21
Current Liabilities	8.70	14.08	12.68	3.12	9.99	1.80
Total Liabilities	20.10	49.12	72.83	58.09	117.91	70.42

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.90	1.09	1.23	4.88	1.04	3.11
Current Assets	10.50	48.04	71.60	53.22	116.87	67.30
Total Assets	21.90	49.12	72.83	58.09	117.91	70.42
Total Debt*	0.04	0.27	0.26	0.52	0.47	0.78
Net Current Assets	--	33.96	58.91	56.73	106.89	44.90

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-60.30	-43.75	-49.04	-35.16	-25.96
Cash Flow from Investing Activities	--	--	48.97	--	--	0.03
Cash from Financing Activities	--	37.18	-0.03	-0.21	98.04	74.00
Net Cash Inflow / Outflow	--	--	--	--	62.88	48.07

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.38	-1.64	-3.02	-4.82	-3.59	-0.44
Cash EPS ($)	--	-1.64	-3.02	-4.82	-3.59	-0.44
Adjusted Book Value ($)	--	0.85	2.23	4.83	9.54	8.83
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.46	-1.62	-4.33	-3.11	-3.40
Free Cash Flow per Share ($)	--	-1.46	-1.62	-4.33	-3.11	-3.40

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-141.16	-140.89	-66.78	-45.98	-10.04
ROE (%)	-834.64	-141.94	-141.86	-67.18	-46.31	-10.32
ROA (%)	-190.64	-110.79	-124.38	-62.04	-43.10	-8.70
EBIT Margin (%)	-10,576.52	--	--	-14,505.33	-2,704.67	-34.19
Net Margin (%)	-22,170.65	--	--	-14,558.93	-3,620.61	-31.39
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	31.45	--	-1.00	-0.75	-0.85	25.81
EBIT Growth (%)	26.65	13.95	-49.67	-34.08	-1,080.39	89.55
Net Profit Growth (%)	-27.89	17.02	-49.12	-34.52	-1,098.32	89.71
EPS Growth (%)	0.23	0.46	0.37	-0.34	-7.09	0.97
Book Value Growth (%)	-94.53	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-1.76	-1.37	-0.09	-0.90	-5.07
Price / Book Value	27.25	3.38	1.86	0.09	0.34	0.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.47	-1.02	-0.51	0.70	1.92	14.21
Close Price ($)	0.45	2.88	4.15	4.50	32.40	22.50
High Price ($)	4.79	5.00	10.20	34.49	41.70	31.80
Low Price ($)	0.22	1.68	1.24	4.00	13.30	10.20
Market Cap ($ Cr)	116.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.01	0.00	0.01	0.00	0.01
Short term debt to equity ratio	0.01	0.01	0.00	0.00	0.00	0.00
Current Ratio	1.21	3.41	5.64	17.07	11.70	37.37
Quick Ratio	1.21	--	--	16.62	--	36.83
Interest Coverage	-4,357.87	--	-16,282.80	-1,007.31	-989.51	-88.13

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	363.47	79.27	20.02
Asset Turnover	0.01	--	--	0.00	0.02	0.26
Receivable days	--	--	--	1,242.82	389.84	39.93
Inventory Days	--	--	1,194.12	1,228.65	--	72.58
Payable days	--	409,372.20	3,424.11	2,521.55	--	196.29
Cash Conversion Cycle	--	--	--	-50.07	--	-83.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.